These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 25733062)

  • 41. Upregulation of CD80 on glomerular podocytes plays an important role in development of proteinuria following pig-to-baboon xeno-renal transplantation - an experimental study.
    Rivard CJ; Tanabe T; Lanaspa MA; Watanabe H; Nomura S; Andres-Hernando A; Garth K; Sekijima M; Ishimoto T; Ariyoshi Y; Garcia GE; Shah J; Lennan B; Tasaki M; Pomposelli T; Shimizu A; Sachs DH; Johnson RJ; Yamada K
    Transpl Int; 2018 Oct; 31(10):1164-1177. PubMed ID: 29722117
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CTLA-4 and autoimmunity: new insights into the dual regulator of tolerance.
    Romo-Tena J; Gómez-Martín D; Alcocer-Varela J
    Autoimmun Rev; 2013 Oct; 12(12):1171-6. PubMed ID: 23851140
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Costimulation of T-cell activation and virus production by B7 antigen on activated CD4+ T cells from human immunodeficiency virus type 1-infected donors.
    Haffar OK; Smithgall MD; Bradshaw J; Brady B; Damle NK; Linsley PS
    Proc Natl Acad Sci U S A; 1993 Dec; 90(23):11094-8. PubMed ID: 7504294
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of the CD28-B7 costimulatory pathways in T cell-dependent B cell responses.
    Hathcock KS; Hodes RJ
    Adv Immunol; 1996; 62():131-66. PubMed ID: 8781268
    [No Abstract]   [Full Text] [Related]  

  • 45. Podocyte-Targeted Treatment for Proteinuric Kidney Disease.
    Mundel P
    Semin Nephrol; 2016 Nov; 36(6):459-462. PubMed ID: 27987545
    [No Abstract]   [Full Text] [Related]  

  • 46. The role of B7-1 in proteinuria of glomerular origin.
    Novelli R; Benigni A; Remuzzi G
    Nat Rev Nephrol; 2018 Sep; 14(9):589-596. PubMed ID: 29959373
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CTLA-4: From mechanism to autoimmune therapy.
    Hosseini A; Gharibi T; Marofi F; Babaloo Z; Baradaran B
    Int Immunopharmacol; 2020 Mar; 80():106221. PubMed ID: 32007707
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Absence of B7-dependent responses in CD28-deficient mice.
    Green JM; Noel PJ; Sperling AI; Walunas TL; Gray GS; Bluestone JA; Thompson CB
    Immunity; 1994 Sep; 1(6):501-8. PubMed ID: 7534617
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunosuppression through blockade of CD28:B7-mediated costimulatory signals.
    Judge TA; Tang A; Turka LA
    Immunol Res; 1996; 15(1):38-49. PubMed ID: 8739564
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regulation of T and B cell responses by modulating interactions between CD28/CTLA4 and their ligands, CD80 and CD86.
    Lane P
    Ann N Y Acad Sci; 1997 Apr; 815():392-400. PubMed ID: 9186685
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [CD28/B7 costimulating signal and its clinical significance].
    Qu MH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Jun; 10(3):265-7. PubMed ID: 12513801
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acquisition of CD80 by human T cells at early stages of activation: functional involvement of CD80 acquisition in T cell to T cell interaction.
    Tatari-Calderone Z; Semnani RT; Nutman TB; Schlom J; Sabzevari H
    J Immunol; 2002 Dec; 169(11):6162-9. PubMed ID: 12444120
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CD28 function: a balance of costimulatory and regulatory signals.
    Bour-Jordan H; Blueston JA
    J Clin Immunol; 2002 Jan; 22(1):1-7. PubMed ID: 11958588
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In situ expression of B7 and CD28 receptor families in human malignant melanoma: relevance for T-cell-mediated anti-tumor immunity.
    Denfeld RW; Dietrich A; Wuttig C; Tanczos E; Weiss JM; Vanscheidt W; Schöpf E; Simon JC
    Int J Cancer; 1995 Jul; 62(3):259-65. PubMed ID: 7543078
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of B7 costimulation in T-cell immunity.
    Harris NL; Ronchese F
    Immunol Cell Biol; 1999 Aug; 77(4):304-11. PubMed ID: 10457196
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CD28-b7 blockade in organ dysfunction secondary to cold ischemia/reperfusion injury.
    Chandraker A; Takada M; Nadeau KC; Peach R; Tilney NL; Sayegh MH
    Kidney Int; 1997 Dec; 52(6):1678-84. PubMed ID: 9407517
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mutational analysis and an alternatively spliced product of B7 defines its CD28/CTLA4-binding site on immunoglobulin C-like domain.
    Guo Y; Wu Y; Zhao M; Kong XP; Liu Y
    J Exp Med; 1995 Apr; 181(4):1345-55. PubMed ID: 7535334
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Complementarity determining region 1 (CDR1)- and CDR3-analogous regions in CTLA-4 and CD28 determine the binding to B7-1.
    Peach RJ; Bajorath J; Brady W; Leytze G; Greene J; Naemura J; Linsley PS
    J Exp Med; 1994 Dec; 180(6):2049-58. PubMed ID: 7964482
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CD28-B7 interactions are not required for intrathymic clonal deletion.
    Jones LA; Izon DJ; Nieland JD; Linsley PS; Kruisbeek AM
    Int Immunol; 1993 May; 5(5):503-12. PubMed ID: 7686392
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Detection of a soluble form of B7-1 (CD80) in synovial fluid from patients with arthritis using monoclonal antibodies against distinct epitopes of human B7-1.
    McHugh RS; Ratnoff WD; Gilmartin R; Sell KW; Selvaraj P
    Clin Immunol Immunopathol; 1998 Apr; 87(1):50-9. PubMed ID: 9576010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.